As of 2025-07-04, the Fair Value of Recro Pharma Inc (REPH) is -1.57 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.09 USD, the upside of Recro Pharma Inc is -174.95%.
With the market price of 2.09 USD and our fair value calculation, Recro Pharma Inc (REPH) is not a good investment. Investing in REPH stocks now will result in a potential loss of 174.95%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| - | - | - | - | - | 5Y Avg | |
| Net income | - | - | - | - | - | - |
| YoY growth | - | - | - | - | - | -% |
| Market Cap (mil) | 98.21 |
| P/E | |
| Forward P/E |
| EPS | -0.31 |
| Avg earnings growth rate | -% |
| TTM earnings | -11.37 |